{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:20:44Z","timestamp":1785122444528,"version":"3.55.0"},"reference-count":12,"publisher":"Azerbaijan Medical Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>M\u0259qal\u0259d\u0259 Bak\u0131 \u015f\u0259h\u0259ri \u0259halisind\u0259 da\u011f\u0131n\u0131q sklerozun klinik-epidemioloji x\u00fcsusiyy\u0259tl\u0259ri v\u0259 apar\u0131lan m\u00fcalic\u0259nin n\u0259tic\u0259l\u0259ri haqda m\u0259lumat verilir. 2013-2020-ci ill\u0259r m\u00fcdd\u0259tind\u0259 559 da\u011f\u0131n\u0131q sklerozlu Bak\u0131 \u015f\u0259h\u0259ri sakini m\u00fc\u015fahid\u0259y\u0259 c\u0259lb edilmi\u015fdir. X\u0259st\u0259l\u0259rd\u0259n 392 (70,1 %) n\u0259f\u0259ri qad\u0131n v\u0259 167 (29,9 %) n\u0259f\u0259ri is\u0259 ki\u015fi olmu\u015fdur. X\u0259st\u0259liyin diaqnozu 2010-cu ilin McDonald kriteriyalar\u0131 \u0259sas\u0131nda qoyulmu\u015fdur. B\u00fct\u00fcn pasiyetl\u0259rd\u0259 standart klinik nevroloji m\u00fcayin\u0259, \u0259lillik d\u0259r\u0259c\u0259sini qiym\u0259tl\u0259ndirilm\u0259si \u015fkalas\u0131 (EDSS), ba\u015f v\u0259 onur\u011fa beynin MRT m\u00fcayin\u0259si, t\u00f6r\u0259dil\u0259n g\u00f6rm\u0259 potensiallar\u0131, qan\u0131n v\u0259 onur\u011fa beyni mayesinin biokimy\u0259vi v\u0259 immunoferment m\u00fcayin\u0259si apar\u0131lm\u0131\u015fd\u0131r. Statistik t\u0259hlil zaman\u0131 parametrik v\u0259 qeyri-parametrik \u00fcsullardan istifad\u0259 edilmi\u015fdir. A\u015fkar olunmu\u015fdur ki, Bak\u0131 \u015f\u0259h\u0259ri da\u011f\u0131n\u0131q sklerozun yay\u0131lmas\u0131na g\u00f6r\u0259 orta risk zonas\u0131na aid edil\u0259 bil\u0259r. Da\u011f\u0131n\u0131q skleroz \u00fczr\u0259 x\u0259st\u0259l\u0259nm\u0259 g\u00f6st\u0259rici 2013-2019-ci ill\u0259rd\u0259 \u00fcmum\u0259n stabil qalm\u0131\u015fd\u0131r. M\u00fc\u0259yy\u0259n edilmi\u015fdir ki, pasiyentl\u0259rin \u0259ks\u0259riyy\u0259ti residivli da\u011f\u0131n\u0131q skleroz fenotipin\u0259 aiddir v\u0259 bu fenotip x\u0259st\u0259l\u0259rin daha cavan ya\u015fda olmas\u0131 v\u0259 x\u0259st\u0259liyin gedi\u015fini d\u0259yi\u015f\u0259n preparatlara m\u00fcsb\u0259t cavab reaksiyas\u0131 il\u0259 s\u0259ciyy\u0259l\u0259nir.<\/jats:p>\n                                                                                            <jats:p>The article presents information about the clinical and epidemiological characteristics and results of treatment of multiple sclerosis in the population of the city of Baku. In the period from 2013 to 2020, 559 residents of the city of Baku with multiple sclerosis were involved in the study. Of these, 392 (70.1%) patients were women and 167 (29.9%) men. The disease was diagnosed based on the 2010 McDonald criteria. All patients underwent a standard clinical and neurological examination, health status assessment according to the disability scale (EDSS), MRI of the brain and spinal cord, visual evoked potentials, biochemical and enzyme immunoassays of blood and cerebrospinal fluid. Parametric and nonparametric methods were used for statistical analysis. It was revealed that in terms of the prevalence of multiple sclerosis, the city of Baku can be classified as a medium-risk zone. The incidence rate of multiple sclerosis remained generally stable from 2013 to 2019. It was found that the majority of patients had a relapsing phenotype of multiple sclerosis, which is characterized by a younger age of patients and a positive reaction to disease-modifying drugs.<\/jats:p>\n                                                    <jats:p>\u0412 \u0441\u0442\u0430\u0442\u044c\u0435 \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d\u044b \u0441\u0432\u0435\u0434\u0435\u043d\u0438\u044f \u043e \u043a\u043b\u0438\u043d\u0438\u043a\u043e-\u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0430\u0440\u0430\u043a\u0442\u0435\u0440\u0438\u0441\u0442\u0438\u043a\u0435 \u0438 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u043e\u0433\u043e \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430 \u0443 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f \u0433\u043e\u0440\u043e\u0434\u0430 \u0411\u0430\u043a\u0443. \u0412 \u043f\u0435\u0440\u0438\u043e\u0434 2013-2020 \u0433\u043e\u0434\u0430 \u043a \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044e \u0431\u044b\u043b\u043e \u043f\u0440\u0438\u0432\u043b\u0435\u0447\u0435\u043d\u043e 559 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u044b\u043c \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u043e\u043c \u0436\u0438\u0442\u0435\u043b\u0435\u0439 \u0433\u043e\u0440\u043e\u0434\u0430 \u0411\u0430\u043a\u0443. \u0418\u0437 \u043d\u0438\u0445 392 (70,1%) \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0431\u044b\u043b\u0438 \u0436\u0435\u043d\u0449\u0438\u043d\u0430\u043c\u0438 \u0438 167 (29,9%) \u043c\u0443\u0436\u0447\u0438\u043d\u0430\u043c\u0438. \u0417\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0435 \u0431\u044b\u043b\u043e \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u0440\u043e\u0432\u0430\u043d\u043e \u043d\u0430 \u043e\u0441\u043d\u043e\u0432\u0430\u043d\u0438\u0438 \u043a\u0440\u0438\u0442\u0435\u0440\u0438\u0435\u0432 McDonald 2010 \u0433\u043e\u0434\u0430. \u0412\u0441\u0435\u043c \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u0430\u043c \u043f\u0440\u043e\u0432\u0435\u0434\u0435\u043d\u043e \u0441\u0442\u0430\u043d\u0434\u0430\u0440\u0442\u043d\u043e\u0435 \u043a\u043b\u0438\u043d\u0438\u043a\u043e-\u043d\u0435\u0432\u0440\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u043e\u0431\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435, \u043e\u0446\u0435\u043d\u043a\u0430 \u0441\u043e\u0441\u0442\u043e\u044f\u043d\u0438\u044f \u0437\u0434\u043e\u0440\u043e\u0432\u044c\u044f \u043f\u043e \u0448\u043a\u0430\u043b\u0435 \u0438\u043d\u0432\u0430\u043b\u0438\u0434\u043d\u043e\u0441\u0442\u0438 (EDSS), \u041c\u0420\u0422 \u0433\u043e\u043b\u043e\u0432\u043d\u043e\u0433\u043e \u0438 \u0441\u043f\u0438\u043d\u043d\u043e\u0433\u043e \u043c\u043e\u0437\u0433\u0430, \u0432\u044b\u0437\u0432\u0430\u043d\u043d\u044b\u0435 \u0437\u0440\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0435 \u043f\u043e\u0442\u0435\u043d\u0446\u0438\u0430\u043b\u044b, \u0431\u0438\u043e\u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0438 \u0438\u043c\u043c\u0443\u043d\u043e\u0444\u0435\u0440\u043c\u0435\u043d\u0442\u043d\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 \u043a\u0440\u043e\u0432\u0438 \u0438 \u0441\u043f\u0438\u043d\u043d\u043e\u043c\u043e\u0437\u0433\u043e\u0432\u043e\u0439 \u0436\u0438\u0434\u043a\u043e\u0441\u0442\u0438. \u0414\u043b\u044f \u0441\u0442\u0430\u0442\u0438\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0430\u043d\u0430\u043b\u0438\u0437\u0430 \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043b\u0438\u0441\u044c \u043f\u0430\u0440\u0430\u043c\u0435\u0442\u0440\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0438 \u043d\u0435\u043f\u0430\u0440\u0430\u043c\u0435\u0442\u0440\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043c\u0435\u0442\u043e\u0434\u044b. \u0412\u044b\u044f\u0432\u043b\u0435\u043d\u043e, \u0447\u0442\u043e \u043f\u043e \u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u043e\u0433\u043e \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430, \u0433\u043e\u0440\u043e\u0434 \u0411\u0430\u043a\u0443 \u043c\u043e\u0436\u043d\u043e \u043e\u0442\u043d\u0435\u0441\u0442\u0438 \u043a \u0437\u043e\u043d\u0435 \u0441\u0440\u0435\u0434\u043d\u0435\u0433\u043e \u0440\u0438\u0441\u043a\u0430. \u0423\u0440\u043e\u0432\u0435\u043d\u044c \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u0435\u043c\u043e\u0441\u0442\u0438 \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u044b\u043c \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u043e\u043c \u0432 2013-2019 \u0433\u043e\u0434\u0430\u0445 \u043e\u0441\u0442\u0430\u0432\u0430\u043b\u0441\u044f \u0432 \u0446\u0435\u043b\u043e\u043c \u0441\u0442\u0430\u0431\u0438\u043b\u044c\u043d\u044b\u043c. \u0423\u0441\u0442\u0430\u043d\u043e\u0432\u043b\u0435\u043d\u043e, \u0447\u0442\u043e \u0443 \u0431\u043e\u043b\u044c\u0448\u0438\u043d\u0441\u0442\u0432\u0430 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u043d\u0430\u0431\u043b\u044e\u0434\u0430\u043b\u0441\u044f \u0440\u0435\u0446\u0438\u0434\u0438\u0432\u0438\u0440\u0443\u044e\u0449\u0438\u0439 \u0444\u0435\u043d\u043e\u0442\u0438\u043f \u0440\u0430\u0441\u0441\u0435\u044f\u043d\u043d\u043e\u0433\u043e \u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430, \u0434\u043b\u044f \u043a\u043e\u0442\u043e\u0440\u043e\u0433\u043e \u0445\u0430\u0440\u0430\u043a\u0442\u0435\u0440\u0435\u043d \u0431\u043e\u043b\u0435\u0435 \u043c\u043e\u043b\u043e\u0434\u043e\u0439 \u0432\u043e\u0437\u0440\u0430\u0441\u0442 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0438 \u043f\u043e\u043b\u043e\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u0430\u044f \u0440\u0435\u0430\u043a\u0446\u0438\u044f \u043d\u0430 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u044b \u043c\u043e\u0434\u0438\u0444\u0438\u0446\u0438\u0440\u0443\u044e\u0449\u0438\u0435 \u0442\u0435\u0447\u0435\u043d\u0438\u0435 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f.<\/jats:p>","DOI":"10.34921\/amj.2024.37.98.001","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:49:06Z","timestamp":1723189746000},"page":"168-173","source":"Crossref","is-referenced-by-count":1,"title":["\u041a\u041b\u0418\u041d\u0418\u041a\u041e-\u042d\u041f\u0418\u0414\u0415\u041c\u0418\u041e\u041b\u041e\u0413\u0418\u0427\u0415\u0421\u041a\u0410\u042f \u0425\u0410\u0420\u0410\u041a\u0422\u0415\u0420\u0418\u0421\u0422\u0418\u041a\u0410 \u0418 \u0420\u0415\u0417\u0423\u041b\u042c\u0422\u0410\u0422\u042b \u041b\u0415\u0427\u0415\u041d\u0418\u042f \u0420\u0410\u0421\u0421\u0415\u042f\u041d\u041d\u041e\u0413\u041e \u0421\u041a\u041b\u0415\u0420\u041e\u0417\u0410"],"prefix":"10.34921","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-4444","authenticated-orcid":false,"given":"A.\u0130.","family":"Quliyeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"50808","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Hauser S.L., Cree B.A.C. Treatment of Multiple Sclerosis: A Review \/\/ Am J Med. 2020 Dec;133(12):1380- 1390.e2. doi: 10.1016\/j.amjmed.2020.05.049. Epub 2020 Jul 17. PMID: 32682869; PMCID: PMC7704606.","DOI":"10.1016\/j.amjmed.2020.05.049"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Walton C., King R., Rechtman L., Kaye W., Leray E., Marrie R.A., et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition\/\/Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177\/1352458520970841. Epub 2020 Nov 11. PMID: 33174475; PMCID: PMC7720355.","DOI":"10.1177\/1352458520970841"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Branco M., Alves I., Martins da Silva A., Pinheiro J., S\u00e1 M.J., et al. The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study\/\/ BMC Neurol. 2020 May 19;20(1):195. doi: 10.1186\/s12883-020-01755-8. PMID: 32429866; PMCID: PMC7236954.","DOI":"10.1186\/s12883-020-01755-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"GBD 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016\/\/ Lancet Neurol. 2019 Mar;18(3):269-285. doi: 10.1016\/S1474-4422(18)30443-5. Epub 2019 Jan 21. PMID: 30679040; PMCID: PMC6372756.","DOI":"10.1016\/S1474-4422(18)30443-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Lublin F.D., Reingold S.C., Cohen J.A., Cutter G.R., S\u00f8rensen P.S., Thompson A.J., et al. Defining the clinical course of multiple sclerosis: the 2013 revisions\/\/ Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212\/WNL.0000000000000560. Epub 2014 May 28. PMID: 24871874; PMCID: PMC4117366.","DOI":"10.1212\/WNL.0000000000000560"},{"key":"6","unstructured":"Hart F.M., Bainbridge J. Current and emerging treatment of multiple sclerosis\/\/ Am J Manag Care. 2016 Jun;22(6 Suppl):s159-70. PMID: 27356025."},{"key":"7","unstructured":"Mazyar Hashemilar, Dariush Savadi Ouskui, Mehdi Farhoudi, Hormoz Ayromlou, Abolfazl Asadollahi. Multiple sclerosis in East Azerbaijan, North West Iran \/\/ Neurology Asia 2011; 16(2) : 127 \u2013 131"},{"key":"8","doi-asserted-by":"crossref","unstructured":"\u00dclk\u00fc T\u00fcrk B\u00f6r\u00fc ,Arda Duman ,Ahmet \u015e\u00fckr\u00fc Kulualp ,Ne\u015fe G\u00fcler ,Mustafa Ta\u015fdemir ,\u00dcmit Y\u0131lmaz, et al. Multiple sclerosis prevalence study: The comparison of 3 coastal cities, located in the black sea and mediterranean regions of Turkey \/\/ Medicine (Baltimore). 2018 Oct; 97 (42): e12856. Published online 2018 Oct 19. doi:10.1097\/MD.0000000000012856","DOI":"10.1097\/MD.0000000000012856"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Boyko A., Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies \/\/Brain Sci. 2020 May 18;10(5):305. doi: 10.3390\/brainsci10050305. PMID: 32443404; PMCID: PMC7288193.","DOI":"10.3390\/brainsci10050305"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection \/\/ Clinical Microbiology Reviews, - 1993 Oct, 6(4), - p.382-427.","DOI":"10.1128\/CMR.6.4.382-427.1993"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Clare Walton, Rachel King, Lindsay Rechtman, Wendy Kaye, Emmanuelle Leray, Ruth Ann Marrie et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition\/\/ Mult Scler. 2020 Dec; 26(14): 1816\u20131821. Published online 2020 Nov 11. doi:10.1177\/1352458520970841.","DOI":"10.1177\/1352458520970841"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Cohan S.L., Hendin B.A., Reder A.T., Smoot K., Avila R., Mendoza J.P. et al. Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)\/\/ CNS Drugs. 2021 Jul;35(7):743-767. doi: 10.1007\/s40263-021-00822-z. Epub 2021 Jul 6. PMID: 34228301; PMCID: PMC8258741.","DOI":"10.1007\/s40263-021-00822-z"}],"container-title":["Azerbaijan Medical Journal"],"original-title":["DA\u011eINIQ SKLEROZ X\u018fST\u018fL\u0130Y\u0130N\u0130N KL\u0130N\u0130K-EP\u0130DEM\u0130OLOJ\u0130 X\u00dcSUS\u0130YY\u018fTL\u018fR\u0130 V\u018f M\u00dcAL\u0130C\u018fS\u0130N\u0130N N\u018fT\u0130C\u018fL\u018fR\u0130"],"language":"az","deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:52:05Z","timestamp":1723189925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.azmedjournal.com\/index.php\/amz\/article\/view\/472"}},"subtitle":["CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND RESULTS OF TREATMENT OF MULTIPLE SCLEROSIS"],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,9,28]]}},"URL":"https:\/\/doi.org\/10.34921\/amj.2024.37.98.001","relation":{},"ISSN":["0005-2523"],"issn-type":[{"value":"0005-2523","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,28]]}}}